In the absence of experimental studies directly investigating the role of NOS3 in thyroid cancer, future research could involve murine models and CRISPR-Cas9 gene editing technologies to explore the functional implications of NOS3 gene polymorphisms. This evidence concerns the gene NOS3 and thyroid gland carcinoma.